Ipsen/Galderma's Azzalure approved for aesthetic use in Europe
This article was originally published in Scrip
Executive Summary
Ipsen/Galderma's muscle relaxant for aesthetic use, Azzalure (botulinum type A toxin-haemagglutinin complex), has received marketing authorisations in15 European countries including the UK, Spain, and France for the treatment of glabellar lines.